Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Liabilities and Shareholders Equity (2016 - 2018)

Historic Liabilities and Shareholders Equity for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $10.6 million.

  • Armata Pharmaceuticals' Liabilities and Shareholders Equity fell 2294.46% to $10.6 million in Q3 2018 from the same period last year, while for Dec 2018 it was $36.7 million, marking a year-over-year decrease of 3237.62%. This contributed to the annual value of $11.1 million for FY2017, which is 3864.38% down from last year.
  • As of Q3 2018, Armata Pharmaceuticals' Liabilities and Shareholders Equity stood at $10.6 million, which was down 2294.46% from $11.7 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Liabilities and Shareholders Equity's 5-year high stood at $38.6 million during Q1 2015, with a 5-year trough of $10.6 million in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' median Liabilities and Shareholders Equity value was $28.3 million (recorded in 2016), while the average stood at $24.5 million.
  • In the last 5 years, Armata Pharmaceuticals' Liabilities and Shareholders Equity surged by 1005.0% in 2015 and then crashed by 4939.32% in 2017.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Liabilities and Shareholders Equity stood at $28.6 million in 2014, then increased by 10.05% to $31.5 million in 2015, then tumbled by 42.36% to $18.2 million in 2016, then crashed by 38.64% to $11.1 million in 2017, then decreased by 4.66% to $10.6 million in 2018.
  • Its Liabilities and Shareholders Equity was $10.6 million in Q3 2018, compared to $11.7 million in Q2 2018 and $14.4 million in Q1 2018.